Key facts, as of
As of October 8, 2026, Baxter International (BAX) trades at $23.97, up 4.7% over the past year. Its 52-week range runs from $15.73 to $30.00; the price is 20.1% below that high. It is 74.8% below its all-time high of $95.19, reached in April 2020. Over the 10 years to the end of September 2026, with dividends reinvested, it returned −41.2%, against +312.9% for the S&P 500 (SPY). It sits 14.7% above its 200-day average of $20.91, the usual sign of a long-term uptrend. Its 30-day volatility is 23.3% annualized, which we rate medium risk. It has a dividend yield of 0.17%.
Cite: Portfolio Terminal, "Baxter International (BAX) stock analysis", 2026-10-08. https://portfolio-terminal.com/analyse/bax
Where it trades today
trading 58% of the way up its 52-week range
How the price has moved
How far it is from its record
Baxter International (BAX) is 74.8% below its all-time high of $95.19, reached in April 2020. Over the 10 years to the end of September 2026, with dividends reinvested, it returned −41.2%, against +312.9% for the S&P 500 (SPY).
What to weigh before acting
What Matters Now
- The read on the stock is often driven by pipeline durability, reimbursement pressure, and whether new launches can offset patent cliffs.
- BAX carries a beta of 0.65, which means the stock should be judged on how it affects total portfolio swings, not just on standalone upside.
- Relative performance versus UNH, JNJ, PFE matters here because leadership inside healthcare rarely stays static for long.
Portfolio Use Case
- BAX is more useful for investors comparing conviction names inside healthcare than for someone looking for a passive “set and forget” holding.
- The beta profile suggests it can fit a quality or lower-volatility sleeve more naturally than a high-octane tactical basket.
- The stock becomes more useful when paired with an explicit catalyst watchlist, because sector sentiment can shift quickly around policy, rates, or pipeline news.
What Would Change the View
- Volatility is already above the sector norm, so even a correct long-term thesis can be painful if the position size is too aggressive.
- The view would need revisiting if peers such as UNH, JNJ, PFE start winning the marginal flow or posting cleaner operating momentum.
Methodology
- Price, market cap, beta, yield, and liquidity fields for BAX come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Healthcare so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as UNH, JNJ, PFE.
Sources
- Yahoo Finance quote dataopen →
Live quote, valuation, beta, yield, and volume fields used for BAX. Last refresh: Oct 8, 2026, 10:10 AM.
- Portfolio Terminal methodologyopen →
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
- Peer set and coverage context
Comparative context for this page is anchored around nearby tracked names such as UNH, JNJ, PFE.
What Baxter International does
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision…
Employees
37,500
Industry
Medical Instruments & Supplies
Headquarters
Deerfield, United States
What analysts expect
BAX carries a hold consensus from 12 analysts, with an average price target of $27.92 versus $23.97 today (+16.5%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
BAX generated $11.47B in trailing revenue (5.3% year over year), with a -9.3% net margin, and $1.00B of free cash flow, against $7.52B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $11.24B | $3.38B | $177.00M | -$957.00M | -$1.87 | $323.00M |
| 2024 | $10.64B | $3.98B | $439.00M | -$649.00M | -$1.27 | $559.00M |
| 2023 | $10.36B | $4.15B | $707.00M | $2.66B | $5.25 | $1.29B |
| 2022 | $10.06B | $3.55B | -$33.00M | -$2.43B | -$4.83 | $576.00M |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
BAX is in 6 of the 30 ETFs we track. It weighs most in XLV: 0.20% of the fund, holding #53 of 62.
How it sits in healthcare
Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.
The companies it competes with
BAX beside the healthcare names it is usually measured against.
What the chart is saying
Slipped under its 50-day average inside a longer uptrend.
weakening- Price is 5.3% below its 50-day average and 14.7% above its 200-day.
- The 50-day crossed above the 200-day on 2026-07-13 (a “golden cross”).
- RSI at 48 is neither stretched nor washed out.
- Nothing above has stopped it this year; the nearest floor is $23.61 (-1.5%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
Is BAX a good investment in 2026?
Baxter International operates in the Healthcare sector. Check our real-time metrics above for current valuation.
What is the risk level of BAX?
Based on 30-day volatility of 23.3%, BAX has MEDIUM risk. Beta of 0.65 indicates lower sensitivity to market movements than average.
Does BAX pay dividends?
Yes, Baxter International has a dividend yield of 0.17%.
How far is BAX from its all-time high?
Baxter International is 74.8% below its all-time high of $95.19, reached in April 2020. Over the 10 years to the end of September 2026, with dividends reinvested, it returned −41.2%, against +312.9% for the S&P 500 (SPY).
Which ETFs hold BAX?
6 of the 30 popular ETFs we track hold Baxter International. The largest weights: XLV (0.20%), VYM (0.05%), VOO (0.02%), SPY (0.02%) and IVV (0.02%). Measured on each issuer's full holdings file, dated August 31 to September 24, 2026.
How much of VOO is BAX?
0.02%, as of August 31, 2026: BAX is holding #447 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $0.20 in Baxter International.
What is the analyst price target for BAX?
The average analyst price target for Baxter International (BAX) is $27.92 based on 12 analyst estimates, about 16.5% above the current price of $23.97. The published range runs from $20.00 to $40.00.
How much revenue does BAX generate?
Baxter International reported $11.47B in trailing twelve-month revenue. Revenue growth is running at 5.3% year over year. Net margin sits at -9.3%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare BAX with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.